Atara Biotherapeutics Inc (NASDAQ:ATRA)
| 1.77 Delayed Data As of Sep 20 |  +0.18 / +11.39%Today’s Change | 1.25 Today|||52-Week Range 5.64 | -46.04% Year-to-Date |
Latest ATRA News | Press Releases
No recent news for Atara Biotherapeutics Inc.
Today’s Trading
| Previous close | 1.58 |
| Today’s open | 1.69 |
| Day’s range | 1.65 - 1.96 |
| Volume | 3,280,126 |
| Average volume (3 months) | 1,625,177 |
| Market cap | $154.7M |
Data as of 3:59pm ET, 09/20/2023
Growth & Valuation
| Earnings growth (last year) | +38.36% |
| Earnings growth (this year) | -11.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +212.55% |
| P/E ratio | NM |
| Price/Sales | 5.26 |
| Price/Book | 1.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADVMAdverum Biotechnolog... | +0.02 | +1.26% |
| ADAPAdaptimmune Therapeu... | +0.02 | +2.41% |
| MRSNMersana Therapeutics... | -0.08 | -5.93% |
| HRTXHeron Therapeutics I... | -0.01 | -0.88% |
Data as of 3:59pm ET, 09/20/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $63.6M |
| Annual profit (last year) | -$228.3M |
| Net profit margin | -359.12% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
